Tuberculosis and biologics in rheumatology: India - A special situation.

about

Tuberculosis and biologics in rheumatology: India - A special situation.

Item

http://www.wikidata.org/entity/Q39449936

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tuberculosis and biologics in rheumatology: India - A special situation.

@en

Tuberculosis and biologics in rheumatology: India - A special situation.

@nl

type

Item

label

Tuberculosis and biologics in rheumatology: India - A special situation.

@en

Tuberculosis and biologics in rheumatology: India - A special situation.

@nl

prefLabel

Tuberculosis and biologics in rheumatology: India - A special situation.

@en

Tuberculosis and biologics in rheumatology: India - A special situation.

@nl

P1476

Tuberculosis and biologics in rheumatology: A special situation

@en

P2093

Anuj K Bhatnagar

http://www.w3.org/2001/XMLSchema#string

Ashwani Khanna

http://www.w3.org/2001/XMLSchema#string

Bimlesh D Pandey

http://www.w3.org/2001/XMLSchema#string

Kamal Kumar

http://www.w3.org/2001/XMLSchema#string

Ramesh Jois

http://www.w3.org/2001/XMLSchema#string

Sanjiv Kapoor

http://www.w3.org/2001/XMLSchema#string

Sundeep Upadhyaya

http://www.w3.org/2001/XMLSchema#string

Vishal Goyal

http://www.w3.org/2001/XMLSchema#string

P2860

Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.

Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy.

Cytokine pathways and joint inflammation in rheumatoid arthritis.

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

P304

1313-1325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1756-185X.13129

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rohini Handa

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28730751

http://www.w3.org/2001/XMLSchema#string

P921

India